(𝐏𝐡𝐨𝐭𝐨: 𝐈𝐀𝐍𝐒)

Increase in gap between Covishield doses based on scientific evidence: NTAGI

Increase in gap between Covishield doses based on scientific evidence: NTAGI   –   3 Min Read New Delhi | The decision to increase the gap between two Covishield doses from 4-6 weeks to 12-16 weeks is based on scientific reason regarding behaviour of adenovector vaccines, said Chairman of India’s Covid-19 Working Group of the National Technical Advisory […]

Representational Image | FreePik

Efficacy of Covaxin, Covishield, Sputnik V more or less equivalent: Dr Randeep Guleria

New Delhi | Data available till now shows clearly that efficacy of all vaccines — whether Covaxin, Covishield or Sputnik V — are more or less equivalent, AIIMS Director Dr Randeep Guleria said amid rumours about differentiated abilities of Covid-19 vaccines available in India in terms of production of antibodies or higher seropositivity rate. “We should […]

Representational (Freepik)

After Pfizer, Moderna, now SII seeks indemnity from liability: Sources

New Delhi | Pune-based Serum Institute of India (SII), which manufactures Covishield, has also sought indemnity from liability, expressing the hope that rules would be the same for everyone, said sources. This comes as the Centre is favourably considering granting indemnity against legal proceedings to foreign vaccine makers Pfizer and Moderna prior to their rollout in […]

Adar Poonawalla (File Image | IANS)

“It will take 2-3 years for the entire world population to get fully vaccinated”: Adar Poonawalla

New Delhi | Serum Institute of India CEO Adar Poonawalla has said that the SII never exported vaccines at the cost of the people in India. Defending the move to export vaccines earlier this year by the government and vaccine manufacturers which has been the subject of a heated debate, he said: “Another important factor that […]

(𝐏𝐡𝐨𝐭𝐨: 𝐈𝐀𝐍𝐒)

Powerful Indians making aggressive calls for vaccines: Poonawalla

London | Admitting that he is facing immense pressure from “some of the most powerful people in India” demanding supplies of Covishield, Serum Institute of India (SII) CEO Adar Poonawalla said on Saturday that the company is also planning to start vaccine production in the UK, the media reported. In an interview with The Times, Poonawalla […]